| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |